Press Releases Archives - ExonBio

Exonbio announces the launch of SARS-CoV-2 Neutralizing Anti-spike monoclonal antibody for development of Antigen Assays and Therapeutics for COVID-19

by | Oct 7, 2020

SAN DIEGO, October 7, 2020 /PRNewswire/ — Exonbio, a leading recombinant antibody CRO company now launches the SARS-CoV-2 Spike recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the pandemic. Since the...

Exonbio launches high affinity SARS-CoV-2 rabbit monoclonal antibodies to accelerate the global IVD and research community efforts

by | Jul 23, 2020

SAN DIEGO, July 23, 2020 /PRNewswire/ — Exonbio, a leading recombinant antibody CRO company now launches the SARS-CoV-2 Nucleocapsid recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the pandemic. Since the...